{"version":"1.0","provider_name":"Market Newsdesk","provider_url":"https:\/\/www.marketnewsdesk.com","author_name":"Newsdesk","author_url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/","title":"Guerbet: 2020 annual results - Market Newsdesk","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"3mWF4iAM92\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/guerbet-2020-annual-results\/\">Guerbet: 2020 annual results<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.marketnewsdesk.com\/index.php\/guerbet-2020-annual-results\/embed\/#?secret=3mWF4iAM92\" width=\"600\" height=\"338\" title=\"&#8220;Guerbet: 2020 annual results&#8221; &#8212; Market Newsdesk\" data-secret=\"3mWF4iAM92\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.marketnewsdesk.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"2020 annual results Revenue in line with forecasts despite the health crisis: -12.8% at current exchange rates at \u20ac712.3\u00a0million -10.0% at constant exchange rates (CER)(1)\u00a0 Resilient EBITDA(2) margin at 14.1%\u00a0 Proposed dividend maintained at \u20ac0.70\/share Higher free cash flow at \u20ac40 million with significant working capital improvement Reduction of net debt to \u20ac257 million Confirmation of the strategic roadmap in 2021: Strong growth in Interventional Imaging and delivery systems Reinforcement of the Group\u2019s positions in the APAC region Finalization of clinical studies and continuation of industrial investments for Gadopiclenol Continued investments in Artificial Intelligence A favorable financial outlook: Revenue expected to increase in 2021 despite an ongoing health crisis Extension of 50% of the cost reduction implemented in 2020 Villepinte, &hellip; Continue reading \"\"","thumbnail_url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ3NDM1MSM0MDA5MDAxNjIjMTAxMTUwNQ=="}